18

18 October 2022

Joint research to alleviate the pain of arthritis

A collaboration between Sydney biotech firm Regeneus and a team of researchers from the University of Sydney is developing a novel treatment to interrupt the process that leads to pain in osteoarthritis, improving the quality of life of millions of people worldwide.

18 October 2022

Medtech company partners with researchers to improve arrhythmia outcomes

A Sydney-based medtech firm specialising in heart arrhythmia management has partnered with University of Sydney researchers to develop a novel technology that will improve therapeutic outcomes for people with heart rhythm disorders.